Join us and make your work count. We are a dynamic, fast growing, disruptive and mission-driven healthcare startup, located in the heart of Amsterdam

Join us and make your work count. We are a dynamic, fast growing, disruptive and mission-driven healthcare startup, located in the heart of Amsterdam

 

Teresa's husband was diagnosed with ALS. She spent 11 years as his caregiver and discusses her experiences.

Phase III trial shows that Copiktra (duvelisib) may be an option for patients with relapsed or refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma.

After failing to show a clear benefit over chemotherapy on its own, both the FDA and EMA do not recommend Lartruvo (olaratumab) for use in combination with chemotherapy for new STS patients.

Onpattro (patisiran) is a first-in-class treatment that slows down the progression of hereditary transthyretin amyloidosis (hATTR).

Realistic new year's resolutions for lasting results!

Over 50 countries have approved Spinraza (nusinersen), but not all have made it available to the patients who need it.

New medicine shows statistically significant improvements for prostate cancer patients.

Seeking an creative and skilled Frontend Web Developer to join our international team.